@article{BotzumKlaes2017, author = {Botzum, Edeltraud and Klaes, Sophie}, title = {Evaluation im Kontext sozialr{\"a}umlichen Arbeitens}, series = {KiTa aktuell NRW. Fachzeitschrift f{\"u}r Leitungen, Fachkr{\"a}fte und Tr{\"a}ger}, volume = {2017}, journal = {KiTa aktuell NRW. Fachzeitschrift f{\"u}r Leitungen, Fachkr{\"a}fte und Tr{\"a}ger}, number = {26/9}, editor = {Jasmund, Christina}, publisher = {Carl Link Verlag}, address = {Kronach (Oberfranken)}, pages = {182 -- 185}, year = {2017}, language = {de} } @incollection{BoeningBotzum2017, author = {B{\"o}ning, Sarah-Lena and Botzum, Edeltraud}, title = {Was kann die Gesundheitswirtschaft von der Sozialen Arbeit lernen?}, series = {Neuvermessung der Gesundheitswirtschaft}, booktitle = {Neuvermessung der Gesundheitswirtschaft}, editor = {Matusiewicz, David and Muhrer-Schwaiger, Marco}, publisher = {Springer Gabler Verlag}, address = {Wiesbaden}, publisher = {Technische Hochschule Rosenheim}, pages = {231 -- 240}, year = {2017}, abstract = {Soziale Arbeit leistet einen Beitrag zu mehr sozialer Gerechtigkeit und zum Abbau sozialer Ungleichheit in der Gesellschaft, gleichzeitig gewinnt Gesundheit als Dimension sozialer Ungleichheit zunehmend an Bedeutung. Als Beispiele hierf{\"u}r k{\"o}nnen chronische Erkrankungen, Behinderung und Pflegebed{\"u}rftigkeit genannt werden, die h{\"a}ufig eine gleichberechtigte Teilhabe an der Gesellschaft erschweren, wodurch gesundheitliche Ungleichheit zu sozialer Ungleichheit f{\"u}hrt beziehungsweise diese verst{\"a}rkt. Fragestellungen zu Themen der Gesundheit haben demnach in vielf{\"a}ltiger Hinsicht auch Bezug auf Soziale Arbeit.}, language = {de} } @article{FeketePostBickenbachetal.2017, author = {Fekete, C. and Post, M. and Bickenbach, J. and Middleton, J. and Prodinger, Birgit and Selb, M. and Stucki, G.}, title = {A structured approach to capture the lived experience of spinal cord injury: Data model and questionnaire of the International Spinal Cord Injury Community Survey (InSCI)}, series = {American Journal of physical and rehabilitation medicine}, volume = {96}, journal = {American Journal of physical and rehabilitation medicine}, number = {2}, pages = {S5 -- S16}, year = {2017}, abstract = {The International Spinal Cord Injury (InSCI) community survey has been developed to collect internationally comparable data on the lived experience of persons with spinal cord injury (SCI) in all 6 WHO regions. The InSCI survey provides a crucial first step to generate evidence on functioning, health maintenance, and subjective well-being in persons with SCI globally. A major challenge in setting up the InSCI community survey was to develop a data model and questionnaire that comprehensively captures what matters to people and, at the same time, is feasible and parsimonious in terms of participant's burden. This paper outlines the components of the InSCI data model and presents the question selection to operationalize the data model along the 4 guiding principles of efficiency, feasibility, comparability, and truth and discrimination. The data model consists of 6 components operationalized with 125 questions including functioning (n = 28 body functions and structures; n = 42 activities and participation), contextual factors (n = 26 environmental; n = 19 personal factors), lesion characteristics (n = 2), and appraisal of health and well-being (n = 8). The InSCI questionnaire presents an efficient and feasible solution with satisfying comparability to other populations; however, its validity and reliability still needs to be confirmed.}, language = {en} } @article{SaalBeutnerBogunskietal.2017, author = {Saal, Susanne and Beutner, Katrin and Bogunski, Julia and Oberm{\"u}ller, Kathrin and M{\"u}ller, Martin and Grill, Eva and Meyer, Gabriele}, title = {Interventions for the prevention and treatment of disability due to acquired joint contractures in older people: a systematic review}, series = {Age and Ageing}, journal = {Age and Ageing}, number = {46}, editor = {Oxford Academic,}, year = {2017}, abstract = {Background acquired joint contractures have significant effects on quality of life and functioning. Objective to determine the effects of interventions to prevent and treat disabilities in older people with acquired joint contractures. Methods systematic search (last 8/2016) via Cochrane Library, PubMed, EMBASE, PEDro, CINAHL, trial registries, reference lists of retrieved articles and scientific congress pamphlets. Controlled and randomised controlled trials in English or German comparing an intervention with another intervention or standard care were included. Two independent researchers performed the selection of publications, data extraction and critical appraisal. Results seventeen studies with 992 participants met the inclusion criteria: 16 randomised controlled trials and 1 controlled trial (nursing homes = 4, community settings = 13). The methodological quality of the studies varied. Splints were examined in four studies, stretching exercises in nine studies, and ultrasound, passive movement therapy, bed-positioning and group exercise were each examined in one study. Studies on splints revealed inconclusive results regarding joint mobility or spasticity. Five of seven studies that assessed active stretching programmes for healthy older people reported statistically significant effects on joint mobility in favour of the intervention. Pain, quality of life, activity limitations and participation restrictions were rarely assessed. Conclusion the evidence for the effectiveness of interventions to prevent and treat disability due to joint contractures is weak, particularly for established nursing interventions such as positioning and passive movement. Better understanding is required regarding the delivery of interventions, such as their intensity and duration. In addition to functional issues, activities and social participation should also be studied as outcomes.}, language = {en} } @article{StuckiProdingerBickenbach2017, author = {Stucki, G. and Prodinger, Birgit and Bickenbach, J.}, title = {Four steps to follow when documenting functioning with the International Classification of Functioning, Disability and Health}, series = {European Journal of physical and rehabilitation medicine}, volume = {53}, journal = {European Journal of physical and rehabilitation medicine}, number = {1}, pages = {144 -- 149}, year = {2017}, abstract = {In this methodological note on applying the ICF in rehabilitation, we introduce suitable tools that allow us to document comprehensively and systematically the lived experience of health to guide clinical practice, the management of services, evidence-informed policy and scientific inquiry. The objective of this methodological note is to present the currently available tools with respect to four questions: 1) what ICF domains to document; 2) what perspective to take; 3) what data collection tools to apply; and 4) which approach to use for reporting. The application of these tools is illustrated using the Swiss Spinal Cord Injury (SwiSCI) Cohort Study. Existing ICF Sets provide a practical approach for identifying the domains to document. One can document from the perspective of biological health, lived health, and appraised health. For identifying suitable data collection tools, either existing tools can be linked to the ICF or available ICF-based data collection tools can be used. For reporting, an interval scale metric is suggested. The four step approach presented provides users with a logical sequence to follow when planning the documentation of functioning using the ICF as a health information reference system in practice and research.}, language = {de} } @article{AuerHusmannGillyetal.2017, author = {Auer, Veronika and Husmann, Kai and Gilly, Alexander and Zscheile, Matthias and Blendermann, Hans-Heinrich and Beitzen-Heineke, Ingrid}, title = {Bewertung der Buchenholz-Bereitstellungslogistik. Forschungsprojekt verdeutlicht Vorteile branchen{\"u}bergreifender Zusammenarbeit in der Holzbereitstellungskette.}, series = {Holz-Zentralblatt}, journal = {Holz-Zentralblatt}, year = {2017}, language = {de} } @article{MaritzAronskyProdinger2017, author = {Maritz, R. and Aronsky, D. and Prodinger, Birgit}, title = {The Implementation of the International Classification of Functioning, Disability and Health (ICF) in Electronic Health Records - A Systematic Review}, series = {Applied Clinical Informatics}, volume = {8}, journal = {Applied Clinical Informatics}, number = {3}, pages = {964 -- 980}, year = {2017}, abstract = {Background: The International Classification of Functioning, Disability and Health (ICF) is the World Health Organization's standard for describing health and health-related states. Examples of how the ICF has been used in Electronic Health Records (EHRs) have not been systematically summarized and described yet. Objectives: To provide a systematic review of peer-reviewed literature about the ICF's use in EHRs, including related challenges and benefits. Methods: Peer-reviewed literature, published between January 2001 and July 2015 was retrieved from Medline®, CINAHL®, Scopus®, and ProQuest® Social Sciences using search terms related to ICF and EHR concepts. Publications were categorized according to three groups: Requirement specification, development and implementation. Information extraction was conducted according to a qualitative content analysis method, deductively informed by the evaluation framework for Health Information Systems: Human, Organization and Technology-fit (HOT-fit). Results: Of 325 retrieved articles, 17 publications were included; 4 were categorized as requirement specification, 7 as development, and 6 as implementation publications. Information regarding the HOT-fit evaluation framework was summarized. Main benefits of using the ICF in EHRs were its unique comprehensive perspective on health and its interdisciplinary focus. Main challenges included the fact that the ICF is not structured as a formal terminology as well as the need for a reduced number of ICF codes for more feasible and practical use. Conclusion: Different approaches and technical solutions exist for integrating the ICF in EHRs, such as combining the ICF with other existing standards for EHR or selecting ICF codes with natural language processing. Though the use of the ICF in EHRs is beneficial as this review revealed, the ICF could profit from further improvements such as formalizing the knowledge representation in the ICF to support and enhance interoperability.}, language = {en} } @techreport{Stauss2017, author = {Stauss, Kilian}, title = {Masterprojekt »Pfleiderer-Leuchtende Fl{\"a}chen«}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:861-opus4-2536}, pages = {56}, year = {2017}, abstract = {Das Unternehmen Pfleiderer hat seinen Schwerpunkt in der Herstellung von Holzwerkstoffen und M{\"o}beloberfl{\"a}chen. Das seit {\"u}ber 100 Jahren bestehende Unternehmen geh{\"o}rt zu den gr{\"o}ßten seiner Sparte in Europa. Diese F{\"u}hrungs­position wird durch eine kontinuierliche Forschungs- und Entwicklungsarbeit in den unterschiedlichsten Bereichen stetig ausgebaut. In einem Projekt mit der Hochschule Rosenheim unter Beteiligung der Fakult{\"a}t f{\"u}r Innenarchitektur mit dem Masterstudiengang Innenarchitektur, Spezialisierung M{\"o}beldesign, sollte untersucht werden, wie fl{\"a}chiges, m{\"o}belgebundenes Licht im Ladenbau und Shopdesign zum Einsatz kommen kann und welche Vorteile eine solche Beleuchtung gegen{\"u}ber einer {\"u}blichen architekturgebundenen Beleuchtung besitzt. {\"U}ber Recherchen zu unterschiedlichen Ausgangssituationen am Point of Sale, {\"u}ber Beleuchtungsversuche im Maßstab 1:1 mit fl{\"a}chigem Licht, {\"u}ber Vormodelle und zuletzt {\"u}ber Raumprototypen im Maßstab 1:1 wurden die jeweiligen Thesen dargestellt, {\"u}berpr{\"u}ft und best{\"a}tigt. Es zeigte sich, dass fl{\"a}chiges, m{\"o}belgebundenes Licht einerseits wesentlich mehr und bessere M{\"o}glichkeiten in der Beleuchtung der Ware bringt. Die pr{\"a}sentierten Exponate sehen schlichtweg besser aus. Auf der anderen Seite k{\"o}nnen diese leuchtenden Fl{\"a}chen in intelligente Steuerungen eingebaut werden, die Produktgruppen und Einzelprodukte kundenspezifisch herausstellen k{\"o}nnen. Das leuchtende und intelligente M{\"o}bel wird so zu einem wichtigen Mitspieler im Internet of Things. Die Modelle und Raumprototypen wurden in den Werkst{\"a}tten der Fakult{\"a}t f{\"u}r Innenarchitektur von den am Projekt beteiligten Studierenden selbst gebaut.}, language = {de} } @techreport{KarlingerSchemmeKnorretal.2017, author = {Karlinger, Peter and Schemme, Michael and Knorr, Ludwig and Hummel, Sabine}, title = {Verbund zwischen Organoblech und angespritzten Strukturen}, series = {Forschungsbericht 2016 der Hochschule Rosenheim}, journal = {Forschungsbericht 2016 der Hochschule Rosenheim}, pages = {32 -- 33}, year = {2017}, abstract = {Seit {\"u}ber zehn Jahren erforschen Wissenschaftler und Wissenschaftlerinnen der Fachrichtung Kunststofftechnik an der Hochschule Rosenheim Verbindungstechnologien und -mechanismen zwischen endlosverst{\"a}rkten Thermoplasten und angespritzten Funktionsstrukturen. Besonders die Automobilindustrie hat an den neuen M{\"o}glichkeiten im Leichtbau großes Interesse. Im Projekt "OrganoRipp" untersuchte die Hochschule in Kooperation mit zwei Unternehmenspartnern neue Verbundm{\"o}glichkeiten.}, language = {de} } @article{HummelKnorrKarlingeretal.2017, author = {Hummel, Sabine and Knorr, Ludwig and Karlinger, Peter and Schemme, Michael}, title = {Eine Frage der Haftung}, series = {Kunststoffe}, journal = {Kunststoffe}, number = {07/2017}, publisher = {Carl Hanser Verlag GmbH \& Co. KG}, address = {M{\"u}nchen}, year = {2017}, abstract = {Dieser Artikel gibt ein Einblick in Hinblick auf die Verarbeitung von endlosverst{\"a}rkten Faserhalbzeuge, sogenannten Organobleche, in Kombination mit dem Spritzgießverfahren. Ein Schwerpunkt stellt die Verbundhaftung zwischen den beiden Komponenten dar. Neue Ergebnisse sollen die Gestaltungsrichtlinien der angespritzten Funktionselementen f{\"u}r derartige Bauteile f{\"u}hren. Die Verbundfestigkeit h{\"a}ngt von vielen Einflussfaktoren ab.}, language = {de} } @inproceedings{HummelSchemmeKarlinger2017, author = {Hummel, Sabine and Schemme, Michael and Karlinger, Peter}, title = {Haftungsuntersuchungen f{\"u}r Leichtbauanwendungen}, series = {Technomer 2017 - 25. Fachtagung {\"u}ber Verarbeitung und Anwendung von Polymeren}, booktitle = {Technomer 2017 - 25. Fachtagung {\"u}ber Verarbeitung und Anwendung von Polymeren}, year = {2017}, abstract = {Die Verst{\"a}rkung von Spritzgussteilen mit Faserhalbzeugen gewinnt immer mehr an Bedeutung. F{\"u}r die Einsatztauglichkeit derartiger Bauteile ist die Verbundhaftung zwischen den angespritzten Strukturen und den Faserhalbzeugen essentiell. Der Vortrag befasst sich mit den {\"a}ußeren und prozesstechnischen Einfl{\"u}ssen zu Erh{\"o}hung der Verbundhaftung auf Faserhalbzeugen. Zudem wird ein Einblick in die Pr{\"u}f-und Anlagentechnik in diesem Bereich gegeben.}, language = {de} } @inproceedings{RiederKrommesLang2017, author = {Rieder, Rosina and Krommes, Sandra and Lang, Werner}, title = {Criticality assessment of indium for thin-film photovoltaics in the context of sustainability goals for the German housing sector}, series = {PROCEEDINGS of 33rd PLEA International Conference}, booktitle = {PROCEEDINGS of 33rd PLEA International Conference}, editor = {Brotas, Luisa and Roaf, Susan and Nicol, Fergus}, publisher = {NCEUB}, address = {Edinburgh}, isbn = {978-0-9928957-5-4}, pages = {3692 -- 3698}, year = {2017}, abstract = {In countries with large import dependencies, several studies on strategically important metals have classified raw materials as being critical by combining supply and vulnerability risks. In case of availability, the most critical raw materials are metallic ores and industrial minerals. Within the scope of developing resource efficient buildings, innovative building technologies, such as renewable energy systems, are becoming increasingly integral parts of buildings. Since critical raw materials are essential components in building technologies, they will also play an important role in the housing sector. In this context, it is crucial to consider how sustainability goals in the housing sector are affected by raw material criticality. This paper addresses supply and vulnerability risks of indium, which is contained in thin-film photovoltaics, in order to identify their impacts on future developments in the housing sector. Raw material availability is significantly influenced by the demand and supply of raw materials. To implement risk factors for a criticality assessment in sector-specific material flows, their impacts are analysed and modelled using a dynamic, macro-economic approach. Assuming different energy scenarios in the German housing sector up to 2050, the model reveals the raw material criticality by pointing out supply risks in order to derive recommendations.}, language = {en} } @article{KrommesSchmidt2017, author = {Krommes, Sandra and Schmidt, Felix}, title = {Business model analysis of electric mobility products and services}, series = {International Journal of Automotive Technology and Management IJATM}, volume = {2017}, journal = {International Journal of Automotive Technology and Management IJATM}, number = {Vol. 17 / No. 3}, editor = {Calabrese, Giuseppe Giulio}, pages = {23}, year = {2017}, abstract = {The automotive value chain is experiencing significant transformation. Due to changed mobility use patterns and external conditions such as climate change, scarcity of resources and local air pollution, car manufacturers offer connectivity services and are forced to launch electric mobility. Most of the electric vehicles have additional, complementary products and services. As other market participants also engage in this field car manufacturers must decide whether they transform their business model. Therefore, the questions arise which are the determining key criteria for the business models, what are the business segments car manufacturers are engaged and how car manufacturers are preparing for the transformation. By using qualitative content analysis, key criteria for business model analysis are derived. The portfolio analysis of six car manufacturers in the German market unveils that a few car manufacturers are in an advanced state while others follow with a considerable lag, or even, are behind.}, language = {en} } @article{Werning2017, author = {Werning, Hanno}, title = {Die Klassenvielfalt beim Brandverhalten sinnvoll nutzen}, series = {FeuerTrutz Magazin}, volume = {2017}, journal = {FeuerTrutz Magazin}, number = {5}, publisher = {FeuerTrutz Network GmbH}, address = {K{\"o}ln}, pages = {16 -- 19}, year = {2017}, abstract = {Der Beitrag skizziert die Entstehung der 40 verschiedenen Klassen f{\"u}r das Brandverhalten nach EN 13501-1 und zeigt, wie sich die Klassifizierungskriterien gezielt mit Blick auf die Schutzziele f{\"u}r Abweichungsantr{\"a}ge nach MBO \S 67 nutzen lassen, am Beispiel von echtholzfurnierten Gipsplatten.}, language = {de} } @article{Hammerschmidt2017, author = {Hammerschmidt, Thomas}, title = {Einflussfaktoren auf die Arzneimittelpreisbildung auf Unternehmensebene}, series = {Recht und Politik im Gesundheitswesen}, volume = {2017}, journal = {Recht und Politik im Gesundheitswesen}, number = {23 / 3}, publisher = {Planimed}, address = {Fahrdorf}, pages = {97-111}, year = {2017}, abstract = {Die Entwicklung der Arzneimittelausgaben in der Gesetzlichen Krankenversicherung (GKV) ist dauerhaft ein gesundheitspolitisches Streitthema. Dabei stehen vor allem die Arzneimittelpreise neuer, patentgesch{\"u}tzter Medikamente im Fokus der gesundheitspolitischen Diskussion. In diesen Diskussionen wird h{\"a}ufig von „Mondpreisen" gesprochen, die in keiner Relation zum Nutzen der neuen Arzneimittel st{\"u}nden. Die Diskussion zwischen „Mondpreisen" und der seitens der Arzneimittelhersteller notwendigen Preisen zur Amortisierung von Forschungs- und Entwicklungskosten greift zu kurz. Die vorliegende Analyse leistet einen Beitrag dazu, die Faktoren detaillierter zu beleuchten, die bei der Preisfindung forschender pharmazeutischer Unternehmen f{\"u}r neue Arzneimittel eine Rolle spielen. Die Analyse folgt dabei der Perspektive des Arzneimittelherstellers. Zum einen muss das Unternehmen die betriebswirtschaftlichen Rahmenbedingungen ber{\"u}cksichtigen, die eine Untergrenze f{\"u}r den erforderlichen Preis determinieren. Zum anderen bestimmt der Wert des Medikamentes in seinem Wettbewerbsumfeld eine Obergrenze f{\"u}r den Preis. Aus betriebswirtschaftlicher Perspektive l{\"a}sst sich festhalten, dass die umsatzst{\"a}rksten Pharmaunternehmen einen hohen Reingewinn erzielen, die Dividendenrendite von 3\% eine im Gesundheitssektor hohe Profitabilit{\"a}t aus Sicht der Kapitalgeber ausweist. Die Pharmabranche erzielt im Vergleich zu anderen Sektoren wie der Technologiebranche oder dem Rohstoffsektor jedoch keine {\"U}berrenditen. Unternehmensseitig stellen die Marketing-, Vertriebs- und Verwaltungs- (29\%), die Herstellungs- (29\%) und Forschungs- und Entwicklungs- (F\&E) (17\%) sowie die Kapitalkosten (14\%) die wesentlichen Kostenbl{\"o}cke dar. Die Produktionskosten spielen in der Diskussion um Arzneimittelpreise eine untergeordnete Rolle, was bei der Gr{\"o}ße dieses Kostenblocks erstaunt. Die vorliegende Studie erg{\"a}nzt die bisherigen, h{\"a}ufig kritisierten Sch{\"a}tzungen von F\&E-Kosten um einen neuen Ansatz auf Basis der in Gesch{\"a}ftsberichten ausgewiesenen F\&E-Kosten. F\&E ist gepr{\"a}gt durch steigende Ausgaben, lange Kapitalbindung und eine Vielzahl nicht erfolgreicher Entwicklungsprogramme - nur eines von acht klinischen Entwicklungsprogrammen f{\"u}hrt zu einer erfolgreichen Zulassung. Die F\&E-Kosten eines Arzneimittels inklusive der Weiterentwicklungen in andere Indikationsgebiete oder anderer Darreichungsformen liegen zwischen 2,2 und 3,1 Mrd. \$ mit einem Mittelwert von 2,6 Mrd. \$. Nur ca. 60\% der Arzneimittel erwirtschaften die F\&E-Kosten im Verlaufe des Produktlebenszyklus. Ber{\"u}cksichtigt man alle Kosten, so m{\"u}sste ein Arzneimittel durchschnittlich ca. 15 Mrd. \$ Umsatz {\"u}ber den gesamten Produktlebenszyklus erreichen, was nur von jedem vierten bis siebten Medikament erreicht wird. Die Preissetzung f{\"u}r neue Arzneimittel erfolgt derart, dass eine notwendige Querfinanzierung von nicht erfolgreichen Arzneimittelentwicklungen und Medikamenten mit zu niedrigem Umsatz erm{\"o}glicht wird. Neben den betriebswirtschaftlichen Rahmenbedingungen spielt letztlich f{\"u}r die Preisfindung der Wert des Arzneimittels im Vergleich zu relevanten Wettbewerbsprodukten die entscheidende Rolle. In der Regel ist das Wettbewerbsumfeld durch einen monopolistischen Wettbewerb gepr{\"a}gt. Arzneimittelhersteller ber{\"u}cksichtigen in rationaler Weise Produkteigenschaften, die {\"u}ber den patientenrelevanten Nutzen im AMNOG hinausgehen zur Preisdifferenzierung im wettbewerblichen Umfeld. Zu derartigen Produkteigenschaften z{\"a}hlen Verbesserung von sogenannten Surrogatendpunkten, aber auch k{\"u}rzere Behandlungsdauern, weniger invasive Darreichungsformen und l{\"a}nger getaktete, weniger h{\"a}ufige Arzneimitteleinnahme, welche einen Wert des Arzneimittels aus Sicht des Patienten widerspiegeln.}, language = {de} } @inproceedings{SiggKrause2017, author = {Sigg, Ferdinand and Krause, Harald}, title = {Modellierung und Bewertung von strombasierten Versorgungskonzepten f{\"u}r hocheffiziente Geb{\"a}ude}, series = {Tagungsband der 21. Internationalen Passivhaustagung 2017, Wien.}, booktitle = {Tagungsband der 21. Internationalen Passivhaustagung 2017, Wien.}, year = {2017}, language = {de} } @article{Werning2017, author = {Werning, Hanno}, title = {Nach vorn - in kleinen Schritten; DIN 4102-4/A1 - Stand Januar 2017}, series = {Trockenbau Akustik}, volume = {2017}, journal = {Trockenbau Akustik}, number = {2/2017}, publisher = {Verlagsgesellschaft Rudolf M{\"u}ller GmbH \& Co. KG}, address = {K{\"o}ln}, pages = {26 -- 29}, year = {2017}, abstract = {Der Beitrag berichtet {\"u}ber den aktuellen Stand der Erstellung und die zu erwartenden Inhalte von E DIN 4102-4/A1 zum Zeitpunkt Januar 2017 f{\"u}r Trockenbaukonstruktionen.}, language = {de} } @techreport{Hammerschmidt2017, type = {Working Paper}, author = {Hammerschmidt, Thomas}, title = {Factors influencing the outcomes of the AMNOG benefit assessment}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:861-opus4-2291}, pages = {16}, year = {2017}, abstract = {Background: Since 2011, pharmaceutical companies have to proof the added benefit of new drugs in Germany. The benefit assessment is in relation to an "appropriate comparator therapy" (ACT) defined by the Federal Joint Committee (FJC). Based on the benefit assessment, a reimbursement price is negotiated. In order to proof added benefit, it is essential to provide evidence on patient-relevant outcomes from direct head-to-head comparisons with the ACT. Indirect treatment comparisons and evidence based on surrogate parameters are usually not sufficient. FJC often splits the indication into different subpopulations. Objective: The objective was to analyse whether factors beyond the clinical evidence have influence on the benefit assessment of the FJC. Methods: All benefit assessments between 2011 and 2015 were included in the analysis. The benefit for each drug was calculated by weighting the evidence grade, strength of evidence and size of subpopulations. Drugs were then clustered in high, low or no benefit. Univariate logistic regression was used to identify variables with potential influence (p<0.25). Those variables were included in a multivariate logistic regression model and variables with p>0.1 were excluded in a stepwise approach. Results: The final multivariate logistic regression identified that following variables increase the chance of getting a higher benefit: pharmacologically innovative drug, drugs in disease areas with high unmet medical need, drugs in oncology or infectious diseases, and drugs for which the FJC can split the assessment into subpopulations. Conclusions: The analysis identified variables beyond clinical evidence that influence the benefit assessment by the FJC and provided a better understanding of decision making by the FJC.}, subject = {AMNOG}, language = {en} }